World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
12706
World Ranking
2460
National Ranking
6

Ursula Fearon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ursula Fearon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 282 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ursula Fearon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ursula Fearon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ursula Fearon is affiliated with Trinity College Dublin in Ireland. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Rheumatology and Immunology as key subfields. The main topics in their work include rheumatoid arthritis research and therapies, systemic lupus erythematosus research, autoimmune and inflammatory disorders research, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy, and immune responses, as well as psoriasis treatment and pathogenesis.

Fearon has contributed to numerous publications, with a consistent presence in several high-profile journals. Frequent venues for their work include:

  • Annals of the Rheumatic Diseases
  • Frontiers in Immunology
  • Lara D. Veeken
  • Arthritis Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)

Among recent papers authored by Ursula Fearon are:

  • "MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes" (2020, Arthritis & Rheumatology)
  • "The PD-1:PD-L1 axis in Inflammatory Arthritis" (2021, BMC Rheumatology)
  • "Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease" (2021, Clinical & Translational Immunology)
  • "Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications" (2022, Nature Reviews Rheumatology)
  • "Serum miRNA Signature in Rheumatoid Arthritis and "At-Risk Individuals"" (2021, Frontiers in Immunology)

Their collaborative work includes frequent partnerships with other researchers. Among coauthors who have contributed extensively to shared research are:

  • Douglas J. Veale
  • Mary Canavan
  • Achilleas Floudas
  • Viviana Marzaioli
  • Megan M. Hanlon

Ursula Fearon's research contributions mainly address complex immune-mediated diseases, focusing on the molecular and cellular mechanisms underlying chronic inflammatory conditions. Their work on cellular metabolic adaptations and signaling pathways in rheumatoid arthritis integrates immunology and molecular biology approaches to explore therapeutic implications.

Best Publications

  • The role of metabolism in the pathogenesis of osteoarthritis

    Ali Mobasheri;Ali Mobasheri;Margaret P. Rayman;Oreste Gualillo;Jérémie Sellam

  • Hypoxia, oxidative stress and inflammation

    Trudy McGarry;Monika Biniecka;Douglas J. Veale;Ursula Fearon

  • The pathogenesis of psoriatic arthritis.

    Douglas J Veale;Ursula Fearon;Ursula Fearon

  • Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

    Ursula Fearon;Mary Canavan;Monika Biniecka;Douglas J. Veale

  • Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

    Simon Rauber;Markus Luber;Stefanie Weber;Lisa Maul

  • Angiopoietins, growth factors, and vascular morphology in early arthritis.

    Ursula Fearon;Konstantina Griosios;Alexander Fraser;Richard Reece

  • Synovial tissue hypoxia and inflammation in vivo

    C T Ng;M Biniecka;A Kennedy;J McCormick

  • Synovial tissue research: a state-of-the-art review

    Carl Orr;Elsa Sousa;David L Boyle;Maya H Buch

  • Dysregulated bioenergetics: a key regulator of joint inflammation

    M Biniecka;M Canavan;T McGarry;W Gao

  • Macrophages in synovial inflammation.

    Aisling Kennedy;Ursula Fearon;Douglas J. Veale;Catherine Godson

  • Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis

    Wei Gao;Jennifer McCormick;Mary Connolly;Emese Balogh

  • Angiogenesis and blood vessel stability in inflammatory arthritis.

    Aisling Kennedy;Chin Teck Ng;Monika Biniecka;Tajvur Saber

  • Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.

    Sharee A. Basdeo;Deborah Cluxton;Jamal Sulaimani;Barry Moran

  • Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors

    W Gao;T McGarry;C Orr;J McCormick

  • Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies

    Ellen M Moran;Ronan Mullan;Jennifer McCormick;Mary Connolly

  • Hypoxia Activates NF-κB–Dependent Gene Expression Through the Canonical Signaling Pathway

    Kathryn M. Oliver;John F. Garvey;Chin Teck Ng;Douglas J. Veale

  • Acute‐phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF‐κB–dependent signal transduction pathway

    Ronan H. Mullan;Barry Bresnihan;Lucy Golden-Mason;Trevor Markham

  • JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis.

    Trudy McGarry;Carl Orr;Sarah Wade;Monika Biniecka

  • Turnover of Type II Collagen and Aggrecan in Cartilage Matrix at the Onset of Inflammatory Arthritis in Humans Relationship to Mediators of Systemic and Local Inflammation

    Alexander Fraser;Ursula Fearon;R. Clark Billinghurst;Mirela Ionescu

  • The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis.

    Carl K. Orr;Aurelie Najm;Francis Young;Trudy McGarry

  • Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.

    Barry Bresnihan;Eliza Pontifex;Rogier M. Thurlings;Marjolein Vinkenoog

Frequent Co-Authors

Douglas J. Veale
Douglas J. Veale University College Dublin
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Barry Bresnihan
Barry Bresnihan University College Dublin
Paul Emery
Paul Emery University of Leeds
John D. Isaacs
John D. Isaacs Newcastle University
Danielle M. Gerlag
Danielle M. Gerlag UCB Pharma (United Kingdom)
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Costantino Pitzalis
Costantino Pitzalis Queen Mary University of London
Zoltán Szekanecz
Zoltán Szekanecz University of Debrecen
Anthony G. Wilson
Anthony G. Wilson University College Dublin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open new career avenues. Many professionals start with foundational nursing qualifications before specializing. Programs like easiest absn programs to get into offer accelerated routes to earn a Bachelor of Science in Nursing, ideal for career changers or recent graduates eager to enter the field quickly.

Nurses looking to advance further may consider an accelerated nurse practitioner program. These programs focus on developing clinical expertise necessary for specialized patient care and can complement knowledge in Immunology.

For registered nurses without prior nursing degrees, online RN programs for non nurses in Florida offer a flexible path to obtain licensure and foundational nursing skills, which is crucial for entering advanced immunological roles in healthcare settings.

Lastly, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care NP (ACNP) through programs like the fnp to acnp route allows nurses to focus on critical care, often intersecting with immunological research and patient treatment strategies. These educational pathways create versatile opportunities in the evolving healthcare landscape.

Best Scientists Citing Ursula Fearon

Trending Scientists

Recently Published Articles